FDA Inspection 736338 — OneLegacy

OneLegacy — FEI 3004627938

The FDA completed an inspection of OneLegacy on July 21, 2011 in Redlands, CA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
July 21, 2011
Fiscal Year
2011
Product Type
Biologics
Project Area
Human Cellular, Tissue, and Gene Therapies
Location
Redlands, CA (United States)